Linezolid: In Infants and Children with Severe Gram-Positive Infections

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.5, Iss.6, 2003-01, pp. : 419-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linezolid in Infants and Children with Severe Gram-Positive Infections: A Viewpoint by Jaime G. Deville

By Deville J.

Pediatric Drugs, Vol. 5, Iss. 6, 2003-01 ,pp. : 430-431

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

By Falagas Matthew E. Vardakas Konstantinos Z.

Drug Safety, Vol. 31, Iss. 9, 2008-01 ,pp. : 753-768

Adis International

Access to resources Recommend Favorite

Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections

By Plosker Greg L. Figgitt David P.

PharmacoEconomics, Vol. 23, Iss. 9, 2005-01 ,pp. : 945-964

Adis International

Access to resources Recommend Favorite

Linezolid: A Review of its Use in the Management of Serious Gram-Positive Infections

By Perry C.M. Jarvis B.

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 525-551

Adis International

Access to resources Recommend Favorite

`Synercid' - a novel agent for severe multiresistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite